Group A Streptococci from carriage and disease in Portugal: evolution of antimicrobial resistance and T antigenic types during 2000-2002. 2005

R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Monte de Caparica, Portugal.

In this study, we analyzed the antimicrobial resistance properties and T antigenic types of 511 isolates collected in Lisbon district, Portugal, from throat swabs of healthy subjects (n=341), during 2000-2002 and from diverse infection sites (n=170) of outpatients and inpatients, during 1999-2002. Erythromycin resistance was higher in tonsillitis/pharyngitis (27.4%) and skin infection isolates (21.1%), than in carriage and invasive isolates (<or=10%). Differences in erythromycin resistance among children and adults were noticed only for carriage isolates (9.3% in children and 21.1% in adults). Most erythromycin-resistant isolates from carriage (82.4%) and tonsillitis/pharyngitis (71.9%) showed the M phenotype. All M phenotype isolates (n=53) carried mef(A), whereas all MLS(B) phenotype isolates (n=19) carried erm(B) and not erm(A). Resistance to tetracycline [mediated by tet(M) in most isolates] was <or=6% in tonsillitis/pharyngitis and carriage isolates, 36.8% in skin infection isolates, and 44.1% in invasive isolates. The M phenotype increased since 2000, linked to a decrease of tetracycline resistance, and was predominantly associated with T1 in 2000-2001 and T12 in 2002 among carriage isolates, and with T8/25/Imp19 through 2000-2002 among tonsillitis/pharyngitis isolates. The majority (53%) of the tetracycline-resistant invasive isolates were nontypable. All isolates were susceptible to penicillin and chloramphenicol. This study showed that tetracycline and macrolide resistance frequency and phenotypes differ among GAS from various origins and changed over time. Moreover, T typing suggested that most drug-resistant isolates causing oropharyngeal carriage are distinct from the majority of isolates causing noninvasive and invasive infection.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011174 Portugal A country in southwestern Europe, bordering the North Atlantic Ocean, west of Spain. The capital is Lisbon. Madeira Island,Portuguese Republic
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
July 1970, Applied microbiology,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
July 2005, International journal of antimicrobial agents,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
November 2012, BMC microbiology,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
June 1982, The Journal of infectious diseases,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
March 2004, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
June 1981, The Journal of infectious diseases,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
June 1982, The Journal of infectious diseases,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
December 2004, Epidemiology and infection,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
February 2007, The Pediatric infectious disease journal,
R Pires, and D Rolo, and L Gama-Norton, and A Morais, and L Lito, and M J Salgado, and C Johansson, and G Möllerberg, and B Henriques-Normark, and J Gonçalo-Marques, and I Santos-Sanches
January 1993, The Journal of hospital infection,
Copied contents to your clipboard!